Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · IEX Real-Time Price · USD
8.64
-0.36 (-4.00%)
At close: Jul 19, 2024, 4:00 PM
8.55
-0.09 (-1.04%)
Pre-market: Jul 22, 2024, 7:30 AM EDT
MRVI Employees
Maravai LifeSciences Holdings had 650 employees as of December 31, 2023. The number of employees increased by 40 or 6.56% compared to the previous year.
Employees
650
Change (1Y)
40
Growth (1Y)
6.56%
Revenue / Employee
$421,691
Profits / Employee
-$201,600
Market Cap
1.15B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 650 | 40 | 6.56% |
Dec 31, 2022 | 610 | 140 | 29.79% |
Dec 31, 2021 | 470 | 60 | 14.63% |
Dec 31, 2020 | 410 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Owens & Minor | 22,200 |
Omnicell | 3,650 |
Artivion | 1,500 |
AtriCure | 1,050 |
Establishment Labs Holdings | 908 |
Autolus Therapeutics | 463 |
Relay Therapeutics | 323 |
Arcutis Biotherapeutics | 296 |
MRVI News
- 12 days ago - Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024 - GlobeNewsWire
- 19 days ago - Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report - GlobeNewsWire
- 4 weeks ago - Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics - Accesswire
- 2 months ago - TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center - Business Wire
- 2 months ago - Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule - GlobeNewsWire
- 2 months ago - Maravai LifeSciences Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology - Business Wire
- 3 months ago - TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production - Business Wire